1st Quarter - Report

MARIJUANA POLICY PROJECT for MARIJUANA POLICY PROJECT

Firm
Client
Income
—
Expenses
$11,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

MPP believes marijuana should be taxed and regulated in a manner similar to alcohol. We lobbied members of Congress to support legislation and congressional action to further that goal. Legislation we support includes but is not limited to HR 499, the Ending Federal Marijuana Prohibition Act, and HR 1523, the Respect State Marijuana Laws Act.

LobbyistCovered position, as disclosed
DAN RIFFLE Director of Federal Policies

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); SENATE; Natl Institutes of Health (NIH); Treasury, Dept of

Bills named: H.R. 1523 (113th), H.R. 499 (113th)

Taxation/Internal Revenue Code TAX

Because marijuana is a "Schedule I" Controlled Substance, section 280E of the Internal Revenue Service Code prevents legitimate, legal marijuana businesses from deducting ordinary business expenses. MPP lobbied to address this inefficient and job-killing policy, including through support of HR 2240, the Small Business Tax Equity Act.

LobbyistCovered position, as disclosed
DAN RIFFLE Director of Federal Policies

Contacted: Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Justice, Dept of (DOJ)

Bills named: H.R. 2240 (113th)

Veterans VET

MPP believes veterans should have access to effective PTSD treatments, including medical marijuana. We lobbied members of congress to and relevant agencies to allow research into this potential treatment option.

LobbyistCovered position, as disclosed
DAN RIFFLE Director of Federal Policies

Contacted: Natl Institutes of Health (NIH); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ)

District of Columbia DOC

MPP lobbied to pass legislation decriminalizing possession of small amounts of marijuana in the District of Columbia. We also lobby members of Congress not to obstruct such legislation from taking effect since Congress effectively has veto power over the DC Council.

LobbyistCovered position, as disclosed
DAN RIFFLE Director of Federal Policies

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Treasury, Dept of; Health & Human Services, Dept of (HHS)

Law Enforcement/Crime/Criminal Justice LAW

MPP believes marijuana prohibition has failed and the individuals who use marijuana should not be subject to arrest or prosecution. We lobbied members of congress on legislation to further this goal, such as HR 499, the Ending Federal Marijuana Prohibition Act, and HR 1523, the Respect State Marijuana Laws Act.

LobbyistCovered position, as disclosed
DAN RIFFLE Director of Federal Policies

Contacted: Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: H.R. 499 (113th), H.R. 1523 (113th)

Banking BAN

Because marijuana is illegal under federal law, banks are reluctant to provide depository services to marijuana businesses. MPP lobbied to address this public safety concern. We lobbied on behalf of HR 2652, the Small Business Access to Banking Act, and lobbied the Departments of Justice and Treasury directly.

LobbyistCovered position, as disclosed
DAN RIFFLE Director of Federal Policies

Contacted: HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE; Treasury, Dept of

Bills named: H.R. 2652 (113th)

Civil Rights/Civil Liberties CIV

MPP believes policies like pre-employment and public benefit eligibility drug testing that discriminate against marijuana users steer those individuals toward more dangerous drugs, like alcohol. Consequently, we lobby members of Congress to oppose such policies.

LobbyistCovered position, as disclosed
DAN RIFFLE Director of Federal Policies

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.